SCHEMBL22954505

SCHEMBL22954505

CC(=O)COC1(C)CCN(I)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8737871 0.76 CYP19A1 (0.37) —
SCHEMBL21427114 0.66 HSD11B1 (0.32) —
SCHEMBL20083937 0.65 EPHX1 (0.39) —
SCHEMBL22758549 0.64 SMN1; SMN2 (0.42) —
SCHEMBL21078006 0.63 DRD2 (0.39) —
SCHEMBL18074854 0.61 TSHR (0.33) —
SCHEMBL31213026 0.61 CYP1A2 (0.38) —
SCHEMBL14215528 0.61 — —
SCHEMBL31213025 0.60 CYP1A2 (0.41) —
SCHEMBL21451469 0.59 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021018118-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 1 PROTEINS JANSSEN PHARMACEUTICA NV (BE) 2021-02-04 — — WO disclosed
Send feedback